Details for New Drug Application (NDA): 206619

NDA 206619 describes VIEKIRA PAK (COPACKAGED), which is a drug marketed by Abbvie and is included in one NDA. There are seventeen patents protecting this drug. Additional details are available on the VIEKIRA PAK (COPACKAGED) profile page.

The generic ingredient in VIEKIRA PAK (COPACKAGED) is dasabuvir sodium; ombitasvir, paritaprevir, ritonavir. Additional details are available on the dasabuvir sodium; ombitasvir, paritaprevir, ritonavir profile page.

Summary for 206619

Tradename:	VIEKIRA PAK (COPACKAGED)
Applicant:	Abbvie
Ingredient:	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir
Patents:	17

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for 206619

Dosage:

TABLET, TABLET;ORAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	EQ 250MG BASE;12.5MG, 75MG, 50MG
Approval Date:	Dec 19, 2014	TE:		RLD:	Yes
Patent:		Patent Expiration:	Oct 18, 2033	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF HCV INFECTION USING DASABUVIR
Patent:		Patent Expiration:	May 17, 2029	Product Flag?	Y	Substance Flag?	Y	Delist Request?
Patented Use:	USE OF DASABUVIR TO INHIBIT VIRAL REPLICATION FOR THE TREATMENT OF HCV INFECTION.
Patent:		Patent Expiration:	Aug 25, 2024	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 206619

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	VIEKIRA PAK (COPACKAGED)	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir	TABLET;ORAL	206619-001	Dec 19, 2014
Abbvie	VIEKIRA PAK (COPACKAGED)	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir	TABLET;ORAL	206619-001	Dec 19, 2014
Abbvie	VIEKIRA PAK (COPACKAGED)	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir	TABLET;ORAL	206619-001	Dec 19, 2014
Abbvie	VIEKIRA PAK (COPACKAGED)	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir	TABLET;ORAL	206619-001	Dec 19, 2014
Abbvie	VIEKIRA PAK (COPACKAGED)	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir	TABLET;ORAL	206619-001	Dec 19, 2014
Abbvie	VIEKIRA PAK (COPACKAGED)	dasabuvir sodium; ombitasvir, paritaprevir, ritonavir	TABLET;ORAL	206619-001	Dec 19, 2014

Complete Access Available with Subscription